These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


739 related items for PubMed ID: 8033212

  • 1. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massagué J.
    Cell; 1994 Jul 15; 78(1):59-66. PubMed ID: 8033212
    [Abstract] [Full Text] [Related]

  • 2. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Toyoshima H, Hunter T.
    Cell; 1994 Jul 15; 78(1):67-74. PubMed ID: 8033213
    [Abstract] [Full Text] [Related]

  • 3. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I, Polyak K, Iavarone A, Massagué J.
    Genes Dev; 1995 Aug 01; 9(15):1831-45. PubMed ID: 7649471
    [Abstract] [Full Text] [Related]

  • 4. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ, Yan S, Herr KD, Wenner CE.
    Cancer Res; 1995 Apr 01; 55(7):1413-6. PubMed ID: 7882344
    [Abstract] [Full Text] [Related]

  • 6. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J.
    Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 03; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts.
    Winston J, Dong F, Pledger WJ.
    J Biol Chem; 1996 May 10; 271(19):11253-60. PubMed ID: 8626675
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells.
    Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, Koh J, Slingerland JM, Stampfer MR.
    Mol Cell Biol; 1997 May 10; 17(5):2458-67. PubMed ID: 9111314
    [Abstract] [Full Text] [Related]

  • 13. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA, Zhang D, Choo CK, Eckert RL, Jacobberger JW.
    Exp Cell Res; 2000 Aug 25; 259(1):149-57. PubMed ID: 10942587
    [Abstract] [Full Text] [Related]

  • 14. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

  • 15. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
    Yamato K, Koseki T, Ohguchi M, Kizaki M, Ikeda Y, Nishihara T.
    Mol Endocrinol; 1997 Jul 05; 11(8):1044-52. PubMed ID: 9212052
    [Abstract] [Full Text] [Related]

  • 16. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
    Taipale M, Tiihonen E, Heiskanen A, Laiho M.
    Exp Cell Res; 2000 Aug 25; 259(1):107-16. PubMed ID: 10942583
    [Abstract] [Full Text] [Related]

  • 17. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 18. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE.
    Genes Dev; 1997 Jun 01; 11(11):1464-78. PubMed ID: 9192873
    [Abstract] [Full Text] [Related]

  • 19. Cloning and characterization of rat p27Kip1, a cyclin-dependent kinase inhibitor.
    Nomura H, Sawada Y, Fujinaga K, Ohtaki S.
    Gene; 1997 Jun 03; 191(2):211-8. PubMed ID: 9218722
    [Abstract] [Full Text] [Related]

  • 20. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.